This pattern of early soluble p-tau elevations many years prior to both cognitive decline and the development of aggregated tau indicates that (1) further mechanistic studies linking Aβ with the cellular response to tau generation are an important point for possible therapeutic focus and (2) understanding the critical links between soluble and insoluble tau pathology could have important therapeutic indications, especially for prevention. The gene discussed is MAPT; the disease is Mental deterioration.